SCHEMBL846441

SCHEMBL846441

O=C(Nc1cnc2ccccc2c1)Oc1ccc(N2CCCCC2)nc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.57
RAB9A P51151 7/20 0.57
KDM4E B2RXH2 5/20 0.57
SMN1; SMN2 Q16637 5/20 0.57
HSD17B10 Q99714 3/20 0.57
TP53 P04637 1/20 0.57
ALDH1A1 P00352 2/20 0.47
LMNA P02545 2/20 0.47
HTT P42858 2/20 0.47
MAPK1 P28482 1/20 0.47
TRPV1 Q8NER1 6/20 0.46
KDR P35968 1/20 0.46
POLB P06746 2/20 0.43
MAPT P10636 1/20 0.43
NOTUM Q6P988 1/20 0.43
TSHR P16473 1/20 0.42
MITF O75030 1/20 0.42
XBP1 P17861 1/20 0.42
PAX8 Q06710 1/20 0.42
KLF5 Q13887 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL847222 0.84 DGAT1 (0.45) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL848254 0.84 FAAH (0.52) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL846151 0.82 NPC1 (0.61) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL846493 0.82 NPC1 (0.61) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL846349 0.82 NPC1 (0.61) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10
SCHEMBL29739388 0.80 GAA (0.52) NPC1RAB9AKDM4EALDH1A1HTT
SCHEMBL896355 0.80 GAA (0.52) NPC1RAB9AKDM4EALDH1A1HTT
SCHEMBL14659243 0.79 MAPT (0.53) NPC1RAB9AKDM4ETP53ALDH1A1
SCHEMBL29739356 0.79 MAPT (0.53) NPC1RAB9AKDM4ETP53ALDH1A1
SCHEMBL4108874 0.78 KDR (0.63) NPC1RAB9AKDM4ESMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1603883-B1 QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR JANSSEN PHARMACEUTICA NV (BE) 2012-03-28 EP claimed